# ASCVD
#learning

**Source** AHA 2013 Cholesterol Guidelines

The concept of there being a way to prevent multiple types of Atherosclerotic Cardiovascular Disease with HMG-CoA-Reductase Inhibitors (i.e. statins)  crystallized in the 2013 AHA Cholesterol guidelines.

According to the pooled cohort equation study by the ACC and AHA one could conceivably lower risk of ASCVD events by …

## Definitions
### ASCVD
**Source**  AHA 2013 Cholesterol Guidelines
* Coronary heart disease (CHD)
* Stroke
* Peripheral arterial disease

### Clinical ASCVD
**Source**  AHA 2013 Cholesterol Guidelines
* acute coronary syndromes
* history of MI
* stable or unstable angina
* coronary or other arterial revascularization
* stroke
* TIA
* peripheral arterial disease
_presumed to be of atherosclerotic origin_

## Official Recs
### NHLBI Grade A - High certainty of substantial net benefit
* Initiate high intensity statins in women and men ≤ 75 years of age with **clinical ASCVD**
* If high intensity statins are not tolerated for some reason try for moderate intensity statins
* Moderate intensity statins for diabetics 40 to 75 years of age for primary prevention (i.e. without **clinical ASCVD** yet)
* Moderate to high intensity for anyone 40 to 75 with estimated 10-year ASCVD risk > 7.5%

### NHLBI Grade B - 

### NHLBI Grade C - 

### Expert Opinion - 

### No comment
* Heart failure
* Hemodialysis